missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Staurosporine, MP Biomedicals™
Shop All MP Biomedical Products
Click to view available options
Quantity:
500 μg
Unit Size:
500µg
Description
Starosporin is used to study the involvement of protein kinases in signal transduction pathways. It arrests normal cells in the G1 checkpoint and is a potent inhibitor of Protein kinase C and other protein kinases in vitro and in cultured cells. It is an inducer of apoptosis in many mammalian cell types.
- Potent inhibitor of phospolipid/calcium dependent and cyclic nucleotide dependent protein kinases
- Useful as a tool for studies on protein phosphorylation in the regulation of cellular functions
- Inhibits the upregulation of VEGF expression in tumor cells
- Partially reverses MDR, sensitizing cells with MDR phenotype to cytotoxic agents
- Inhibits Pgp phosphorylation (functional significance of Pgp phosphorylation is ill defined)
Specifications
Specifications
| Physical Form | Powder |
| Melting Point | 237°C |
| Quantity | 500 μg |
| Solubility Information | May be reconstituted by dissolving the lyophilized reagent in DMSO (5mg/mL, clear, colorless solution), DMF, ethyl acetate (5mg/mL, clear colorless solution) or methanol or water. |
| Formula Weight | 466.5 |
| Percent Purity | ≥98% |
Safety and Handling
Product Identifier
- Staurosporine
- Danger
- Carcinogenicity Category 1B
- Germ cell mutagenicity Category 1B
- H340-May cause genetic defects.
- H350-May cause cancer.
- P101-If medical advice is needed, have product container or label at hand.
- P102-Keep out of reach of children.
- P103-Read label before use.
- P301+P310-IF SWALLOWED: Immediately call a POISON CENTER/doctor /
- P405-Store locked up.
- P501b-Dispose of contents/container in accordance with local/regional/national/international regulations.
- MIXTURE LIST-Contains : Staurosporine
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction